Site position #101
System Labs
Advertises a $99 introductory month and $179 ongoing compounded injection program, with The Pharmacy Hub named as a partner and prescription supply, lab cost and cancellation instructions still needing confirmation.
Our take
System Labs advertises $99 for the first month and $179 monthly thereafter for its compounded GLP-1/GIP program. That simple headline is useful, but the usable supply, patient-lab bill and cancellation route need confirmation. Its general FAQ names a pharmacy; that is a partner disclosure, not an assigned prescription.
Is it for you?Best fit and reasons to look elsewhere
- Best for
- Adults comparing an advertised flat-price compounded injection program who can confirm their formulation, usable supply, testing costs and actual cancellation method before paying.
- Look elsewhere if
- People needing a confirmed branded or oral GLP-1 option, a public numeric dose-and-quantity schedule, or an unambiguous self-service cancellation and refund promise. This inspected offer does not establish those features.
- Semaglutide
- No semaglutide option displayed on the inspected GLP-1 landing page; broader prescribing scope unconfirmed
- Tirzepatide
- Advertised $99 first month, then $179/mo for compounded GLP-1/GIP; confirm the exact formulation and prescription supply
- Coverage
- General FAQ claims all 50 states, subject to treatment, telehealth and pharmacy limits; specific GLP-1 eligibility needs confirmation
- Brand-name
- Not confirmed
In this review
Line System Labs up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.
The GLP-1 landing page displays $99 /first mo. against $179; its FAQ states $179/mo, with supplies and free two-day temperature-controlled shipping. Required patient-lab costs and the exact monthly billing interval remain unspecified. Confirm the full charge and terms for any alternative payment plan.
Start with the second payment
System Labs advertises its compounded GLP-1/GIP program at $99 for the first month, against a crossed-out $179. Its billing FAQ states a flat $179 monthly subscription. The introductory figure therefore belongs in a first-payment budget; it is not the price to use for ongoing care. The page also says there are no per-visit fees and includes injection supplies and temperature-controlled shipping.
That is a comparatively simple advertised bill, but “monthly” does not identify a 28-day, 30-day or calendar-month renewal rule. Obtain the first renewal date and the actual recurring amount before authorizing payment. A six-month total would also need a settled billing calendar and any required patient-testing costs. The headline alone does not answer those questions.
An all-dose label still needs a prescription quantity
The purchase panel says “Monthly Supply (All doses).” The description identifies a subcutaneous injection, and the dosing FAQ says a clinician chooses the starting dose and adjusts it over time. It gives no numeric dose range, vial volume, concentration or number of injections in that monthly supply. “All doses” is an advertised pricing promise, not a dispensing specification.
Ask how many usable doses the proposed prescription contains at your own prescribed amount, whether supplies cover every administration, and what storage and beyond-use instructions apply. Do not infer that a single vial supports every advertised month or that an automatic refill guarantees an uninterrupted usable supply. The page’s general refrigerated-storage instructions do not replace the actual pharmacy label.
The formulation needs a clearer name
The offer is called “Compounded GLP-1/GIP,” with tirzepatide identified in the product information. Before choosing it, obtain the full ingredient list, including any added vitamins, the prescribed strength and the dispensing instructions. A program name is not a complete formulation, and the advertised all-dose price does not tell you which preparation your clinician will prescribe.
The landing page carries a disclosure that its compounded therapies have not been approved by the FDA. Its comparisons with brand-name treatment should not be read as proof of matching clinical results, quality or tolerability. No semaglutide purchase option was displayed on this inspected GLP-1 landing page; that narrower observation is more useful than assuming what the company can never prescribe.
Treat the named pharmacy as a lead to verify
The general FAQ now identifies The Pharmacy Hub at 15600 NW 15th Avenue, Suite C, Miami, Florida. The terms also name it among independent third-party pharmacies and allow patients to choose another pharmacy. That is a meaningful disclosure, but neither document assigns a particular patient’s prescription to that facility or identifies who physically compounds each preparation.
Florida’s record for The Pharmacy Hub LLC matches that address. The record dated October 25, 2026 lists community pharmacy license PH33959 as Clear, expiring February 28, 2027, with no discipline on file. This is one facility’s Florida record, not nationwide dispensing authority, a sterile-production assessment or confirmation of your assigned dispenser. Obtain the actual branch and prescription label before extending that finding.
A medical advisory board is not your treating practice
The landing page names Marc Gruner, Jonathan Hinds and Gregory Tennant as medical advisors. It separately says a licensed clinician reviews the intake and communicates through chat. The advisors’ presence does not identify the clinician who will prescribe for you, establish that person’s license in your state or supply the treating practice’s legal name.
The general FAQ says clinician education and licensing information are available on request and will appear in the patient portal. It describes follow-up and monitoring, and says some therapies require baseline labs, which the provider can order through a local or coordinated laboratory. It does not give a GLP-1-specific testing schedule or establish whether those patient tests are included in $179. Ask for that care and cost explanation together.
General nationwide availability needs a treatment check
The FAQ says System is available in all fifty states, immediately qualifying that statement by treatment availability, telehealth rules and pharmacy licensing. That is a general platform claim. It does not establish that this particular compounded GLP-1/GIP prescription can be shipped to every address in every state.
A buyer needs confirmation of the exact treatment, the clinician’s authority where the patient is physically located and the assigned pharmacy’s ability to dispense there. The terms make treatment availability conditional on supply and other constraints, and say an unfilled order will not be charged if the network cannot supply it. That protection is different from a promise that the advertised program is universally available.
Resolve two different cancellation instructions
The GLP-1 page promises pause or cancellation through the dashboard. The general FAQ instead instructs patients to email support and says a self-cancellation billing portal is coming soon. Those are different instructions for stopping the same kind of recurring payment. Before subscribing, obtain the working method, required notice and next charge date; keep a written cancellation confirmation.
The January 2026 terms say an order canceled before the prescription is sent to the pharmacy will not be billed, although an authorization hold may appear. They call processed-and-shipped medication sales final. The FAQ uses an earlier-sounding boundary: no refunds for services already rendered or prescriptions already ordered. A dashboard cancellation should not be assumed to reverse a pharmacy order or return the latest payment.
Our choice would depend on the answers after the headline
System Labs may appeal to someone who prefers an advertised $179 ongoing program without dose-based price tiers on the landing page. We would confirm the formulation, usable supply, patient-lab cost and cancellation method before treating that simplicity as settled. If a longer payment plan is offered, obtain its full initial charge, renewal amount and refund terms rather than assuming the monthly rules still apply.
For a damaged, defective or incorrect shipment, the terms require contact within seven days and describe discretionary replacement rather than a general money-back guarantee. Anyone who needs a predictable refund or a fully specified prescription before committing should obtain those terms first and compare another provider if the answers remain unclear. We have not used System Labs’ treatment; delivery and treatment outcomes were not tested.
Factor breakdown
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.
Strengths
- The landing page distinguishes its advertised $99 first month from the flat $179 ongoing monthly price
- Injection supplies, free two-day temperature-controlled shipping and no per-visit fees are advertised
- The general FAQ and terms name The Pharmacy Hub as a partner; patients still need to confirm their assigned pharmacy
- The landing page includes a compounded-treatment nonapproval disclosure and describes clinician review and ongoing support
What to consider
- The all-dose monthly package does not disclose a numeric dose range, vial concentration or volume, usable injection count or beyond-use date
- Dashboard cancellation on the landing page conflicts with email instructions and a promised future billing portal in the FAQ; no exact notice cutoff is stated
- The FAQ excludes refunds once prescriptions are ordered, while the terms describe different pharmacy-processing stages; clarify the cutoff before paying
- Patient-lab costs and the GLP-1 testing schedule remain unspecified
- The general claim of availability in all 50 states does not confirm eligibility for this particular treatment
- Named advisors and a pharmacy partner do not identify the assigned treating practice, clinician or physical compounder
- Confirm the exact formulation and available payment plans; the advertised monthly package does not settle either
Bottom line — Grade C
Site position #101 of 540. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.
Closest here
The rankings grading nearest System Labs — the realistic shortlist.
Noom Med combines behavioral coaching and an app with access to independent prescription care; medication inclusion depends on the program.
Factor scores not reassessed.PauseRX is a nationwide compounded GLP-1 telehealth platform notable for its transparency: it names its 503A pharmacy partner (Strive Pharmacy in Gilbert, AZ), its physician network (Beluga Health), and publishes a full FDA compounded-medication disclaimer.
DTC telehealth weight-loss program (Nexus Health Solutions LLC) offering flat-rate compounded semaglutide and tirzepatide, with the consultation, prescription, medication, and shipping bundled into one monthly price.
HeliMeds offers compounded semaglutide and tirzepatide as well as brand-name Wegovy and Zepbound.
Welling Health is a clinician-led metabolic clinic offering compounded GLP-1 therapy on one transparent flat monthly rate: semaglutide from $190/month and tirzepatide from $275/month, with all doses, clinician access, free shipping and a free AI macro-tracker app included.
MyDrHank advertises compounded tablets and injections, but its GLP-1 landing page and separate product pages show different starting prices; get one written offer before choosing a term.
The 23 rankings nearest this one
- #102 9amHealth71.3
- #103 Allara Health71.2
- #104 HealthSource71.2
- #106 Luci71
- #107 Heally70.9
- #108 Layla70.9
- #109 DrBrainRx70.8
- #110 Edessa70.8
- #111 Longevixx70.7
- #112 NuuVim70.6
- #113 TRYM Health70.6
- #114 AlyveRx70.5
- #115 Good Life Meds70.5
- #116 The Edit70.4
- #117 eMI Aesthetics70.3
- #118 RedBox Rx70.2
- #119 Rex MD70.2
- #120 Kina70.1
- #121 OnlineSemaglutide.org70.1
- #122 YOURx Health70
- #123 Remote Pharmacy69.9
- #124 Alternate Health Club69.8
- #125 Navio MD69.8
Prices and terms can change; confirm them with System Labs. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.